טוען...
Future target-based drug discovery for tuberculosis?
New drugs that retain potency against multidrug/extensively drug-resistant strains of Mycobacterium tuberculosis, with the additional benefit of a shortened treatment duration and ease of administration, are urgently needed by tuberculosis (TB) control programs. Efforts to develop this new generation...
שמור ב:
| הוצא לאור ב: | Tuberculosis (Edinb) |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2014
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6072889/ https://ncbi.nlm.nih.gov/pubmed/25458615 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tube.2014.10.003 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|